New Leaf venture capital healthcare fund performance metrics (as of March 31, 2014)
New Leaf venture capital healthcare fund performance metrics (as of March 31, 2014) The document provides detailed financial performance data for a private venture capital firm’s healthcare funds. It contains no references to high‑ranking officials, government agencies, foreign leaders, or illicit financial flows, limiting its investigative value. While the numbers could be useful for market analysis, they offer no concrete leads for wrongdoing or public controversy. Key insights: New Leaf invested $1.02 billion across four Sprout Capital healthcare funds.; Reported IRRs range from 10% to 44% and multiples up to 4.4x.; Performance is benchmarked against S&P 500, Nasdaq, Russell 3000 using PME+ methodology.
Summary
New Leaf venture capital healthcare fund performance metrics (as of March 31, 2014) The document provides detailed financial performance data for a private venture capital firm’s healthcare funds. It contains no references to high‑ranking officials, government agencies, foreign leaders, or illicit financial flows, limiting its investigative value. While the numbers could be useful for market analysis, they offer no concrete leads for wrongdoing or public controversy. Key insights: New Leaf invested $1.02 billion across four Sprout Capital healthcare funds.; Reported IRRs range from 10% to 44% and multiples up to 4.4x.; Performance is benchmarked against S&P 500, Nasdaq, Russell 3000 using PME+ methodology.
Tags
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.